Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Näset Rådmansö AB is a Swedish private investment and asset management firm headquartered in Norrtälje. It serves as the primary holding company for Ove Henning Mattsson, a prominent figure in the Swedish life sciences and chemical industries. The company maintains significant equity stakes in several healthcare-related entities, most notably Micropos Medical AB, a developer of precision radiotherapy technologies for cancer treatment. In addition to its financial portfolio, Näset Rådmansö is involved in horse breeding and operates a conference and event venue on the Rådmansö peninsula. The firm plays a strategic role in the Swedish biotech ecosystem by providing long-term capital and governance through its principal's board positions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Näset Rådmansö.